Company Bio-Rad Laboratories, Inc.

Equities

BIO

US0905722072

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
345.9 USD -1.06% Intraday chart for Bio-Rad Laboratories, Inc. -1.74% +7.12%

Business Summary

Bio-Rad Laboratories, Inc. is specialized in the development, manufacturing and marketing of products used in life sciences research, clinical diagnostics and analytical chemistry. Net sales break down by activity as follows:

- manufacture of clinical diagnostic tests and automated test systems (51.8%). The group also offers test kits, quality control systems and related IT systems;

- manufacture of reagents, equipment and instruments for biological research (48.1%): for the separation, identification and purification of chemical and biological substances (proteins, nucleic acids, bacteria, etc.) for the proteomics, genomics research, biopharmaceuticals, cell biology and food safety markets;

- other (0.1%): in particular, manufacturing of analytical instruments.

At the end of 2022, the Group has 16 production sites in the United States (5), Germany (3), France (2), China (2), Poland, the United Kingdom, Switzerland and Singapore.

Net sales are distributed geographically as follows: the United States (41.2%), Europe (30.4%), Asia (22.8%) and other (5.6%).

Number of employees: 8,030

Sales per Business

USD in Million2022Weight2023Weight Delta
Clinical Diagnostics
55.8 %
1,451 51.8 % 1,489 55.8 % +2.64%
Life Science
44.1 %
1,347 48.1 % 1,178 44.1 % -12.53%
Other
0.1 %
4 0.1 % 4 0.1 % -10.00%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
42.0 %
1,156 41.2 % 1,122 42.0 % -2.91%
Europe
30.7 %
852 30.4 % 820 30.7 % -3.77%
Asia
21.1 %
639 22.8 % 563 21.1 % -11.95%
Other (Primarily Canada and Latin America)
6.2 %
155 5.5 % 167 6.2 % +7.21%

Managers

Managers TitleAgeSince
Chief Executive Officer 74 88-12-31
Director of Finance/CFO 77 83-01-31
Chief Operating Officer 64 19-04-21
Director/Board Member 43 15-12-31
Investor Relations Contact - -
Corporate Officer/Principal 68 -
Corporate Officer/Principal 53 -
Corporate Officer/Principal 62 97-12-31
General Counsel 64 16-05-31
Corporate Officer/Principal - 13-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 64 17-04-24
Founder 97 51-12-31
Director/Board Member 77 17-04-24
Chief Executive Officer 74 88-12-31
Director/Board Member 65 17-04-24
Director/Board Member 66 17-04-24
Director/Board Member 43 15-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,095,930 124,454 ( 2.442 %) 0 66.01 %
Stock B 0 25,169,944 19,853,630 ( 78.88 %) 1,747,438 ( 6.943 %)

Shareholders

NameEquities%Valuation
2,718,118 11.60 % 886 M $
The Vanguard Group, Inc.
10.36 %
2,427,137 10.36 % 791 M $
Vanguard Fiduciary Trust Co.
10.20 %
2,389,889 10.20 % 779 M $
BlackRock Advisors LLC
4.940 %
1,157,188 4.940 % 377 M $
Veritas Asset Management LLP
4.623 %
1,082,895 4.623 % 353 M $
874,914 3.735 % 285 M $
UBS Asset Management (UK) Ltd.
2.148 %
503,208 2.148 % 164 M $
Geode Capital Management LLC
1.964 %
460,086 1.964 % 150 M $
Invesco Advisers, Inc.
1.954 %
457,731 1.954 % 149 M $
AllianceBernstein LP
1.886 %
441,702 1.886 % 144 M $
NameEquities%Valuation
Blue Raven Partners LP
79.67 %
4,060,054 79.67 % 1 326 M $
494,852 9.711 % 162 M $
374,358 7.346 % 122 M $
Parametric Portfolio Associates LLC
4.921 %
250,795 4.921 % 82 M $
Wells Fargo Clearing Services LLC
2.588 %
131,883 2.588 % 43 M $
38,126 0.7482 % 12 M $
3,939 0.0773 % 1 M $
CSS LLC
0.0355 %
1,811 0.0355 % 591 563 $
Buckingham Strategic Wealth LLC
0.0149 %
760 0.0149 % 248 254 $
Whittier Trust Co.
0.003140 %
160 0.003140 % 52 264 $

Holdings

NameEquities%Valuation
12,987,900 34.69% 3,879,140,252 $

Company contact information

Bio-Rad Laboratories, Inc.

1000 Alfred Nobel Drive

94547, Hercules

+510 724 7000

http://www.bio-rad.com
address Bio-Rad Laboratories, Inc.(BIO)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Bio-Rad Laboratories MEPE